As research continues, those involved say this would be a game changer, especially for patients with very limited options.

The US Food and Drug Administration has approved the supplemental biologics licence application (sBLA) of Eisai and Biogen's ...

If you're a caregiver for someone who's living with dementia, the society has material to help you with what to expect as the ...

Xenon is one of the six noble gases. Its name derives from the Greek word for “strange”. In medicine, it has been used as an ...

Scientists have recently shown that both the quality and the amount of sleep we get may influence our risk of developing ...

The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...

Taking too long to enter the phase of sleep in which we dream may be an early sign of Alzheimer's disease. This is the conclusion of an international team of researchers who studied the sleep patterns ...

As research continues, those involved say this would be a game changer, especially for patients with very limited options.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Recent studies have shown that both the quality and the amount of sleep we get may influence our risk of developing Alzheimer ...